Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2021 to Q3 2025

Type / Class
Equity / Common Stock, $0.001 par value
Symbol
IKNA
Shares outstanding
11,181,416
Price per share
$1.43
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-31,761,511
Value change
-$42,557,663
Number of holders
0
Price from insider filings
$1.43
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BML Investment Partners, L.P. 8.5% +11% $4,335,508 +$470,890 4,090,102 +12% Leonard Braden Michael 16 Jun 2025
BIOTECHNOLOGY VALUE FUND L P 8.3% $4,246,958 4,006,564 BVF PARTNERS L P/IL 31 Dec 2024
GILEAD SCIENCES, INC. 3.6% $1,612,591 1,521,312 GILEAD SCIENCES INC 31 Dec 2024
ORBIMED ADVISORS LLC 6.9% -58% $820,179 -$7,669,269 773,754 -90% ORBIMED ADVISORS LLC 25 Jul 2025

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA). This represents 0% of the company’s total 11,181,416 outstanding shares.

Institutional Holders of Ikena Oncology, Inc. - Common Stock, $0.001 par value (IKNA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$42,557,663 $1.43 0
2025 Q2 31,761,826 $42,558,064 -$1,719,668 $1.34 41
2025 Q1 32,747,670 $41,911,271 +$1,300,847 $1.28 46
2024 Q4 31,710,905 $52,000,995 +$1,135,340 $1.64 53
2024 Q3 28,407,567 $49,141,929 -$989,639 $1.73 57
2024 Q2 29,008,151 $47,862,655 -$1,770,172 $1.65 69
2024 Q1 30,097,815 $42,738,138 -$4,428,963 $1.42 56
2023 Q4 0 $0 -$48,392 $1.43 0
2023 Q3 32,711,624 $141,562,227 +$6,440,221 $4.33 58
2023 Q2 31,199,169 $204,665,259 +$41,687,098 $6.56 52
2023 Q1 24,983,174 $86,191,879 -$4,246,851 $3.45 38
2022 Q4 26,264,313 $69,861,906 -$1,368,220 $2.66 34
2022 Q3 26,218,089 $93,072,465 -$2,494,548 $3.55 37
2022 Q2 26,692,274 $118,249,000 -$3,052,708 $4.43 39
2022 Q1 27,400,848 $167,234,122 -$5,437,733 $6.10 45
2021 Q4 27,300,271 $342,431,318 +$20,438,169 $12.54 45
2021 Q3 20,880,074 $271,798,000 -$3,145,383 $12.62 39
2021 Q2 21,064,655 $293,192,000 +$21,244,514 $14.04 41
2021 Q1 19,313,430 $538,519,000 +$538,519,180 $28.25 27